INT2104

INT2104 · Kite, A Gilead Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INT2104, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment [Phase 1]

See pricing